CÔNG TY CỔ PHẦN DƯỢC PHẨM MEDBOLIDE

WORKSHOP INTRODUCING VODOCAT 5 PRODUCT – BREAKTHROUGH IN DIETARY AT CHO RAY HOSPITAL

With the desire to bring a new product, new active ingredients, affordable price and high efficiency in "Diuretic Treatment".

On May 26, 2023, Medbolide CPDP Company participated in organizing group meeting at Cho Ray Hospital's Department of Internal Medicine with 18 specialized doctors and 32 nurses participating.

At the Medbolide exchange, clinical studies comparing the effectiveness of Torsemide versus Furosemide were presented:

Vodocat 5 - Torsemid 5mg provides 3-fold diuresis, clearance independent of kidney function, potassium saving and reduced hospital readmission rate in heart failure patients.

After the report, the doctors had a lot of discussion, concern and sharing about the clinical experience of the drug on patients, thereby opening up a new perspective on the active ingredient Torsemid in "Diuretic TREATMENT". ” in patients with edema due to: heart failure, kidney failure, high blood pressure, cirrhosis.

At the end of the report, the representative of Medbolide company thanked the Head of the Department of Nephrology Dr. Dao Bui Quy Quyen and all the doctors and medical departments and hoped to continue accompanying the Department of Nephrology at Cho Hospital. Ray as well as Cho Ray Hospital in bringing treatment solutions to improve the quality of life for patients.

Pic 1
Pic 2
Pic 3
Pic 4
Readers comments